期刊文献+

灌注加权成像鉴别诊断毛细胞型星形细胞瘤和血管母细胞瘤 被引量:9

Perfusion weighted imaging in differential diagnosis of pilocytic astrocytomas and hemangioblastomas
下载PDF
导出
摘要 目的探讨PWI对毛细胞型星形细胞瘤(PA)和血管母细胞瘤(HB)的鉴别诊断价值。方法回顾分析经手术病理证实的26例PA与16例HB患者的常规MR平扫、PWI及增强扫描资料。计算PA和HB瘤体的相对脑血容量(rCBV)、信号强度-时间曲线的相对信号恢复率(rPSR)。采用独立样本t检验、Z检验及ROC曲线进行统计学分析。结果 PA的rCBV值明显低于HB(1.79±0.99,8.69±2.66),rPSR值明显高于HB(0.99±0.25,0.48±0.28),差异均有统计学意义(P均<0.01)。当rCBV值>3.95或rPSR值≤0.71诊断HB时,rCBV值较rPSR的准确率高[100%(42/42)、88.10%(37/42)]。rCBV和rPSR的曲线下面积分别为1.00、0.90(Z=1.995,P<0.05)。结论 PWI有助于PA和HB的鉴别诊断。 Objective To explore the value of PWI in differential diagnosis of pilocytic astrocytomas(PA)and hemangioblastomas(HB).Methods Totally 26 patients with PA and 16 patients with HB confirmed by surgery and pathology underwent conventional MRI,PWI and enhanced MRI.And the imaging data were retrospectively analyzed.Relative cerebral blood volume(rCBV)and relative percentage of signal intensity recovery(rPSR)of signal intensity-time curve were calculated.Independent samples t test,Ztest and ROC curve were adopted for statistical analysis.Results The rCBV value in PA was significantly lower than that in HB(1.79±0.99 vs 8.69±2.66),while the rPSR value in PA was significantly higher than that in HB(0.99±0.25 vs 0.48±0.28),and the statistical difference were both significant(both P〈0.01).Taking rCBV?3.95 or rPSR≤0.71 diagnosis of HB,the accuracy of rCBV(42/42,100%)was higher than that of rPSR(37/42,88.10%).The area under curve of rCBV was significantly higher than that of rPSR(1.00 vs 0.90,Z=1.995,P〈0.05).Conclusion PWI is helpful for differential diagnosis of PA and HB.
出处 《中国医学影像技术》 CSCD 北大核心 2016年第1期17-20,共4页 Chinese Journal of Medical Imaging Technology
关键词 毛细胞型星形细胞瘤 血管母细胞瘤 磁共振成像 诊断显像 Pilocytic astrocytomas Hemangioblastomas Magnetic resonance imaging Diagnostic imaging
  • 相关文献

参考文献15

  • 1Koeller KK, Rushing EJ. From the archives of the AFIP: Pilo- cytic astrocytoma: Radiologic-pathologic correlation. Radiograph-ics, 2004,24(6) : 1693-1708.
  • 2王鸿帼,陆健,胡振民,邓传宗.颅内血管母细胞瘤的CT及MRI影像分析[J].中国医学影像技术,2004,20(5):689-691. 被引量:4
  • 3Kickingereder P, Wiestler B, Sahm F, et al. Primary central nervous system lymphoma and atypical glioblastoma: Multipara- metric differentiation by using diffusion-, perfusion-, and suscep- tibility-weighted MR imaging. Radiology, 2014,272(3) :843-850.
  • 4Ho CY, Cardinal JS, Kamer AP, et al. Relative cerebral blood volume from dynamic susceptibility contrast perfusion in the grad- ing of pediatric primary brain tumors. Neuroradiology, 2015, 57 (3) :299-306.
  • 5Chinchure S, Thomas B, Wangju S, et al. Mean intensity curve on dynamic contrast-enhanced susceptibility-weighted perfusion MR imaging--review of a new parameter to differentiate intracra- nial tumors. J Neuroradiol, 2011,38(4) : 199-206.
  • 6Xing Z, You RX, Li J, et al. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic sus- ceptibility-weighted contrast-enhanced perfusion MR imaging. Clin Neuroradiol, 2014,24(4) : 329-336.
  • 7Bladowska J, Zimny A, Guzifiski M, et al. Usefulness of perfu- sion weighted magnetic resonance imaging with signal-intensity curves analysis in the differential diagnosis of sellar and parasellar tumors: Preliminary report. Eur J Radiol, 2013, 82 ( 8): 1292-1298.
  • 8张仙海,高明勇,周新韩,谭湘萍,卢瑞梁,赵海,张丽丽.MR灌注加权成像和磁敏感加权成像评价胶质瘤[J].中国医学影像技术,2013,29(12):1937-1940. 被引量:8
  • 9柏亚,钱银锋,余永强,郑斐群,张诚,王海宝.后颅凹肿瘤的磁共振灌注成像[J].实用放射学杂志,2003,19(9):777-780. 被引量:10
  • 10Bing F, Kremer S, Lamalle L, et at. Value of perfusion MRI in the study of pilocytie astrocytoma and hemangioblastoma: Pre- liminary findings. J Neuroradiol, 2009,36(2) : 82-87.

二级参考文献32

  • 1武洪林,钱农,陈君坤,张宗军,卢光明,黄伟,唐晓俊,李林.胶质瘤MR灌注成像与分子病理学的对照研究[J].临床放射学杂志,2006,25(2):112-116. 被引量:15
  • 2[1]Gelabert M,Allut AG,Pravos AG,et al.Cystic hemangioblastoma of the spinal bulb[J].Rev Neurol,1999,29(11):1024-1026.
  • 3[2]Torreggiani WC,Keogh C,Alismail K,et al.Von Hippel-Lindan disease:a radiological essay[J].Clin Radiol,2002,57(8):670-680.
  • 4[3]Hermier M,Cotton F,Saint-Pierre G,et al.Myelopathy and sciatica induced by an extradural S1 root hemangioblastoma[J].Neuroradiology,2002,44(6):494-498.
  • 5[4]Weil RJ,Vortmeyer AO,Zhuang Z,et al.Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without VHL disease[J].J Neurosurg,2002,96(4):775-787.
  • 6[5]Sora S,Ueki K,Saito N,et al.Incidence of VHL disease in hemangioblastoma patients:the University of Tokyo Hospital experince from 1954-1998[J].Acta-Neurochir-(wien),2001,143(9):893-896.
  • 7[6]Conway JE,Chou D,Clatterbuck RE,et al.Hemangioblastomas of the central nervous system in VHL syndrome and sporadic disease[J].Neurosurgery,2001,48(1):55-63.
  • 8[7]Zimmermann M,Seifert V,Schreyer F,et al.Hemangioblastoma:description of a disease picture and report of 41 cases[J].Zentralbl Neurochir,1997,58(1):1-6.
  • 9[8]Wanebo JE,Lonser RR,Glenn GM,et al.The natural history of hemangioblastomas of the central nervous system in patients with VHL disease[J].J Neurosurg,2003,98(1):82-94.
  • 10[10]Goto T,Nishi T,Kunitoku N,et al.Suprasellar hemangioblastoma in a patient with VHL disease confirmed by germline mutation study:case report and review of the literature[J].Surg-Neurol,2001,56(1):22-26.

共引文献24

同被引文献68

引证文献9

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部